All In MedTech

Device Trial Radar · NCT04506866

InterStim Micro Post Market Clinical Follow-up Study (ELITE)

Evaluation of InterStim Micro System Performance and Safety (ELITE) to Confirm Long-Term Outcomes - Post Market Clinical Follow-Up Study

Last checked: Nov 19, 2026Latest source record: Dec 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

148

Actual

Start

Aug 25, 2020

Primary completion

Dec 19, 2022

Study completion Dec 8, 2023

Sponsor

Lead sponsor
MedtronicNeuroNot on our public-company list
Sponsor type
Industry
First posted
Aug 10, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the InterStim Micro System for sacral neuromodulation.

Conditions

  • Overactive Bladder
  • Fecal Incontinence
  • Non-obstructive Urinary Retention

Interventions

  • InterStim MicroDevice

    Eligible subjects will receive InterStim Micro therapy. Commercial devices will be used within their intended use as described in each geography's approved instructions for use

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline for HRQL Total ScoreTime frame: 3 months
  2. Change From Baseline in CCIS ScoreTime frame: 3 months
  3. Change From Baseline in the Number of CISC/DayTime frame: 3 months

Locations

24 sites in 6 countries. Site status is shown where the registry gives one.

  • East Coast Institute for Research

    Jacksonville, Florida

  • Florida Urology Partners

    Tampa, Florida

  • First Urology

    Jeffersonville, Indiana

21 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.